ASP Isotopes (NASDAQ:ASPI) CEO Paul Elliot Mann Sells 83,759 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CEO Paul Mann sold 83,759 shares of ASP Isotopes stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $4.10, for a total value of $343,411.90. Following the sale, the chief executive officer owned 9,328,570 shares in the company, valued at $38,247,137. This trade represents a 0.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Paul Elliot Mann also recently made the following trade(s):

• On Wednesday, September 2nd, Paul Mann sold 83,758 shares of ASP Isotopes stock. The shares were sold at an average price of $3.91, for a total value of $327,493.78.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI traded up $0.30 during trading hours on Friday, reaching $4.20. The stock had a trading volume of 3,831,544 shares, compared to its average volume of 2,936,087. The firm has a market cap of $643.90 million, a price-to-earnings ratio of -3.18 and a beta of 3.59. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a fifty-two week low of $3.51 and a fifty-two week high of $14.49. The firm has a 50-day moving average of $4.37 and a 200-day moving average of $5.20.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The firm had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million.

Hedge Funds Weigh In On ASP Isotopes

A number of large investors have recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of ASP Isotopes during the 2nd quarter worth $57,331,000. HITE Hedge Asset Management LLC purchased a new stake in ASP Isotopes during the fourth quarter worth about $2,407,000. AWM Investment Company Inc. purchased a new stake in ASP Isotopes during the second quarter worth about $9,837,000. Encompass Capital Advisors LLC acquired a new position in ASP Isotopes during the first quarter worth about $30,551,000. Finally, SBI Securities Co. Ltd. grew its position in ASP Isotopes by 196.2% during the fourth quarter. SBI Securities Co. Ltd. now owns 152,120 shares of the company’s stock worth $814,000 after buying an additional 100,769 shares during the period. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.